in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Evonik improves process, lowers price for L-ornithine L-aspartate
8:47 AM MDT | October 24, 2013 | Michael Ravenscroft
Evonik Industries says that it has improved its production process for L-ornithine L-aspartate (LOLA), an active ingredient used in pharmaceuticals. The company says that it has improved the process, which is based on production of L-ornithine by fermentation and biocatalytic production of L-aspartate, at every stage. The new process leads to crystals of particularly high purity with higher stability, Evonik says. The company announced a price reduction of 5–10% in LOLA at the CPhI trade show in Frankfurt, Germany, this week. "We want to share with our...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee